Can Medicaid Managed Care mitigate race/ethnic health disparities in diabetes?
医疗补助管理式医疗能否减轻糖尿病中的种族/民族健康差异?
基本信息
- 批准号:10528738
- 负责人:
- 金额:$ 52.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-23 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAddressAdmission activityAdultAffectAgeAmericanAmericasAmputationBehaviorBlack raceCOVID-19COVID-19 pandemicCOVID-19 pandemic effectsCaringCharacteristicsChronic DiseaseCommunitiesContractsDataData AnalysesData SetDatabasesDiabetes MellitusDiagnosisDistrict of ColumbiaEconomic BurdenEligibility DeterminationEmergency department visitEnrollmentEthnic OriginExpenditureFloridaFutureGoalsHealth Care CostsHeterogeneityHospitalizationHyperglycemiaIncentivesIndigenousInformation SystemsInsurance CarriersInterviewInvestigationKentuckyLatinxLawyersLinkManaged CareManaged Care ProgramsMedicaidMedicare/MedicaidMethodsMinorityNational Institute on Minority Health and Health DisparitiesNon-Insulin-Dependent Diabetes MellitusObesityOccupationsOutcomePatientsPenetrationPerformancePersonsPharmaceutical PreparationsPoliciesPopulationPovertyPreventive carePrimary Health CarePrivatizationProcessQuality of CareRaceResearchRiskSamplingSelection BiasServicesShockTestingTimeTitrationsVariantVulnerable PopulationsWorkbasebeneficiaryblack patientburden of illnesscare outcomescohortcomorbiditycoronavirus diseasecostdata modelingdesigndisenfranchised populationdisparity reductionethnic disparityethnic health disparityethnic minorityevidence baseexperiencefamily burdenfoothealth disparityhigh riskimprovedinsightmedical specialtiesmemberpandemic diseasepeople of colorpost-COVID-19programsresponseservice utilizationsexsocioeconomic disadvantagetrend
项目摘要
ABSTRACT
This study represents a timely investigation that addresses race/ethnic disparities in type 2 diabetes (T2DM)
care over a period that included a major pandemic shock. T2DM is burdensome and disproportionately impacts
vulnerable and disenfranchised populations; of note, there are stark race/ethnic disparities in T2DM care goals,
emergency department (ED) visits, and hospitalizations. Medicaid covers 25% of Americans with T2DM. More
than 80% of Medicaid beneficiaries nationally receive at least some of their care from Medicaid managed care
organizations (MMCO). States contract with private (non-profit or for-profit) MMCOs to lower costs, increase
quality, and pass on financial risks of covering Medicaid beneficiaries. Heterogeneity across and within state
programs can have implications for quality of T2DM care and, specifically, race/ethnic disparities through
benefit generosity or by affecting MMCO entry and post-entry behavior. State policymakers also have
significant influence over marketplaces in which MMCOs compete, which can have consequences for
race/ethnic disparities, given that Medicaid disproportionately covers non-white populations. Little is known
about whether and how MMCOs and the state programs they operate in influence disparities in T2DM care
and, if or how the COVID-19 pandemic changed the trajectory of health disparities. We propose to answer
these unknowns using a convergent mixed-methods study: we will compile a database of MMCO/state
program features that could influence care using a health disparities conceptual framework (Aim 1); we will
empirically explore race/ethnic disparities among adults with T2DM and whether these vary by MMCO/state
features and pre-/post-COVID-19 using comprehensive data from the Transformed Medicaid Statistical
Information System over 2016-2025 (Aims 2 and 3); and we will collect and analyze qualitative data from
Medicaid stakeholders to triangulate and contextualize the quantitative findings (Aim 4). We focus on non-
disabled, non-pregnant 18-64-year-old adults with T2DM who tend to remain stably covered by Medicaid over
time. To reduce selection bias, we focus our analyses on 12 states and the District of Columbia that mandate
enrollment in comprehensive MMCOs. We will use panel data models to examine race/ethnic and sex-specific
receipt of key T2DM services and ED visits and hospitalizations, overall and by MMCO/state features. We will
also follow a continuously enrolled cohort over 2020-2025 to assess if and how MMCO/state program features
moderate the pandemic’s effects on T2DM disparities. Sensitivity analyses will explore the influence of churn.
Further, our preliminary analyses identify Kentucky and Florida as having the lowest and highest disparities in
T2DM care, respectively; we will conduct interviews in these states to examine what MMCO/state features and
implementation might explain these disparities. This policy-relevant work will provide critical insights into how
Medicaid managed care programs can be designed to reduce disparities in chronic disease burdens.
摘要
这项研究是一项及时的研究,旨在解决2型糖尿病(T2 DM)的种族/民族差异
在包括大流行冲击在内的一段时期内提供护理。T2 DM是一种负担,
弱势和被剥夺权利的人群;值得注意的是,T2 DM护理目标存在明显的种族/民族差异,
急诊科(艾德)就诊和住院。医疗补助覆盖了25%的美国T2 DM患者。更
超过80%的医疗补助受益人在全国范围内至少从医疗补助管理医疗中获得部分护理
(MMCO)。国家与私营(非营利或营利)微型和微型企业签订合同,以降低成本,
质量,并传递覆盖医疗补助受益人的财务风险。跨州和州内的异质性
计划可能会影响T2 DM护理质量,特别是种族/民族差异,
受益慷慨或通过影响MMCO进入和进入后的行为。国家政策制定者也有
对MMCO竞争的市场产生重大影响,这可能对
种族/民族差异,因为医疗补助不成比例地覆盖非白人人口。知之甚少
关于MMCO及其运作的州计划是否以及如何影响T2 DM护理的差异
以及COVID-19大流行是否或如何改变了健康差距的轨迹。我们建议回答
这些未知数使用收敛混合方法研究:我们将编译一个数据库的MMCO/状态
使用健康差异概念框架(目标1)可能影响护理的计划功能;我们将
经验性探索T2 DM成人患者中的种族/民族差异,以及这些差异是否因MMCO/州而异
功能和前/后COVID-19使用综合数据从转换医疗补助统计
2016-2025年信息系统(目标2和3);我们将收集和分析来自
医疗补助利益相关者对定量结果进行三角测量和背景分析(目标4)。我们专注于非-
残疾、未怀孕的18-64岁T2 DM成人,他们倾向于保持医疗补助的稳定覆盖,
时间为了减少选择偏差,我们将分析重点放在12个州和哥伦比亚特区,
在综合MMCO中注册。我们将使用面板数据模型来检查种族/民族和性别特异性
接受关键T2 DM服务以及艾德访视和住院,总体和按MMCO/州特征。我们将
我还跟踪了2020-2025年连续登记的队列,以评估MMCO/州计划是否以及如何具有
缓和大流行对T2 DM差异的影响。敏感性分析将探讨流失的影响。
此外,我们的初步分析确定,肯塔基州和佛罗里达在以下方面的差异最低和最高:
T2 DM护理;我们将在这些州进行访谈,以检查MMCO/州的特征,
执行情况可以解释这些差异。这项与政策有关的工作将提供关键的见解,
医疗补助管理式护理计划的设计可以减少慢性病负担的差异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mohammed Kumail Ali其他文献
Mohammed Kumail Ali的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mohammed Kumail Ali', 18)}}的其他基金
Training on ImplemenTAtioN and team Science for NCD Control (TITANS) program
非传染性疾病控制 (TITANS) 计划的实施和团队科学培训
- 批准号:
10665456 - 财政年份:2023
- 资助金额:
$ 52.59万 - 项目类别:
Enhanced BReast and cErvical cAncer screening in Kenya THROUGH implementation science research and training (The BREAKTHROUGH Center)
通过实施科学研究和培训,肯尼亚加强了乳腺癌和宫颈癌筛查(突破中心)
- 批准号:
10738131 - 财政年份:2023
- 资助金额:
$ 52.59万 - 项目类别:
Can Medicaid Managed Care mitigate race/ethnic health disparities in diabetes?
医疗补助管理式医疗能否减轻糖尿病中的种族/民族健康差异?
- 批准号:
10709582 - 财政年份:2022
- 资助金额:
$ 52.59万 - 项目类别:
Integrating HIV and hEART health in South Africa (iHeart-SA)
在南非整合艾滋病毒和心脏抗逆转录病毒治疗 (iHeart-SA)
- 批准号:
10508822 - 财政年份:2020
- 资助金额:
$ 52.59万 - 项目类别:
Integrating HIV and hEART health in South Africa (iHeart-SA)
在南非整合艾滋病毒和心脏抗逆转录病毒治疗 (iHeart-SA)
- 批准号:
10841100 - 财政年份:2020
- 资助金额:
$ 52.59万 - 项目类别:
Integrating HIV and hEART health in South Africa (iHeart-SA)
在南非整合艾滋病毒和心脏抗逆转录病毒治疗 (iHeart-SA)
- 批准号:
10705125 - 财政年份:2020
- 资助金额:
$ 52.59万 - 项目类别:
Integrating HIV and hEART health in South Africa (iHeart-SA)
在南非整合艾滋病毒和心脏抗逆转录病毒治疗 (iHeart-SA)
- 批准号:
10267701 - 财政年份:2020
- 资助金额:
$ 52.59万 - 项目类别:
COllaborative research, implementation, And LEadership training to addresS chronic Conditions across the lifecoursE (COALESCE)
协作研究、实施和领导力培训,以解决整个生命周期的慢性病(COALESCE)
- 批准号:
10210320 - 财政年份:2019
- 资助金额:
$ 52.59万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 52.59万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 52.59万 - 项目类别:
Operating Grants